I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 5 studies | 45% ± 20% | |
| GABAergic neuron | 4 studies | 47% ± 16% | |
| interneuron | 3 studies | 53% ± 17% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 5 studies | 45% ± 20% | |
| GABAergic neuron | 4 studies | 47% ± 16% | |
| interneuron | 3 studies | 53% ± 17% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 35% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 1307.90 | 244 / 245 | 98% | 7.04 | 492 / 502 |
| thymus | 100% | 1212.75 | 651 / 653 | 96% | 5.77 | 582 / 605 |
| breast | 100% | 1897.00 | 459 / 459 | 94% | 8.49 | 1052 / 1118 |
| stomach | 100% | 1164.17 | 359 / 359 | 94% | 8.06 | 269 / 286 |
| intestine | 100% | 976.97 | 963 / 966 | 92% | 7.19 | 486 / 527 |
| brain | 95% | 1319.07 | 2509 / 2642 | 96% | 6.28 | 677 / 705 |
| lung | 100% | 1835.68 | 577 / 578 | 91% | 8.77 | 1052 / 1155 |
| kidney | 97% | 831.80 | 86 / 89 | 94% | 9.74 | 846 / 901 |
| bladder | 100% | 1186.90 | 21 / 21 | 89% | 9.52 | 448 / 504 |
| uterus | 99% | 956.30 | 169 / 170 | 89% | 8.00 | 408 / 459 |
| skin | 92% | 1434.79 | 1670 / 1809 | 89% | 5.82 | 421 / 472 |
| ovary | 99% | 956.86 | 179 / 180 | 82% | 4.09 | 351 / 430 |
| adrenal gland | 92% | 671.05 | 237 / 258 | 85% | 6.52 | 195 / 230 |
| esophagus | 91% | 749.30 | 1311 / 1445 | 83% | 6.72 | 151 / 183 |
| pancreas | 68% | 382.25 | 224 / 328 | 96% | 10.68 | 171 / 178 |
| liver | 92% | 698.07 | 208 / 226 | 71% | 6.34 | 289 / 406 |
| adipose | 100% | 2547.77 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2964.53 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.44 | 1 / 1 |
| spleen | 98% | 786.82 | 237 / 241 | 0% | 0 | 0 / 0 |
| muscle | 98% | 1003.47 | 785 / 803 | 0% | 0 | 0 / 0 |
| heart | 92% | 860.72 | 789 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 79% | 4.47 | 23 / 29 |
| eye | 0% | 0 | 0 / 0 | 66% | 3.34 | 53 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 64% | 3.13 | 29 / 45 |
| peripheral blood | 60% | 971.25 | 560 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006706 | Biological process | steroid catabolic process |
| GO_0008544 | Biological process | epidermis development |
| GO_0007565 | Biological process | female pregnancy |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0005764 | Cellular component | lysosome |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0005768 | Cellular component | endosome |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0004773 | Molecular function | steryl-sulfatase activity |
| GO_0008484 | Molecular function | sulfuric ester hydrolase activity |
| GO_0004065 | Molecular function | arylsulfatase activity |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | STS |
| Protein name | Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase) Steroid sulfatase (Microsomal), isozyme S Steroid sulfatase |
| Synonyms | ARSC1 |
| Description | FUNCTION: Catalyzes the conversion of sulfated steroid precursors, such as dehydroepiandrosterone sulfate (DHEA-S) and estrone sulfate to the free steroid. . |
| Accessions | Q16244 ENST00000664306.2 ENST00000666110.2 A0A590UJY9 Q0W975 P08842 C7BWB5 A0A590UJL0 ENST00000217961.5 ENST00000660000.2 A0A590UJT4 A6PYA4 ENST00000674429.1 |
